IOVANCE BIOTHERAPEUTICS, INC. — Institutional Ownership
Which tracked institutions hold IOVA, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
25
Funds holding
$280634206
Total value held
Buying
20 added/new · 5 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $109092571 | 31080505 | +1562380 | +5.29% |
| 2 | State Street Corp | $61242859 | 17448108 | -2713337 | -13.46% |
| 3 | Goldman Sachs Group Inc | $30747811 | 8760060 | +152496 | +1.77% |
| 4 | Bank Of America Corp /De/ | $29800318 | 8490119 | -5787694 | -40.54% |
| 5 | Morgan Stanley | $21766499 | 6201282 | -2990558 | -32.53% |
| 6 | Northern Trust Corp | $10093096 | 2875526 | +295932 | +11.47% |
| 7 | Wells Fargo & Company/Mn | $5441810 | 1993337 | +475973 | +31.37% |
| 8 | Invesco Ltd. | $3417046 | 1251665 | +306195 | +32.39% |
| 9 | Bank Of New York Mellon Corp | $3358299 | 956780 | +1313 | +0.14% |
| 10 | Royal Bank Of Canada | $2194000 | 625035 | — | NEW BUY |
| 11 | Raymond James Financial Inc | $1493477 | 425492 | +21051 | +5.20% |
| 12 | Janus Henderson Group Plc | $497977 | 141672 | — | NEW BUY |
| 13 | Sei Investments Co | $428810 | 122180 | — | NEW BUY |
| 14 | Citigroup Inc | $288124 | 105540 | -304025 | -74.23% |
| 15 | Barclays Plc | $221762 | 63180 | — | NEW BUY |
| 16 | Prudential Financial Inc | $182327 | 51945 | +34280 | +194.06% |
| 17 | Pnc Financial Services Group, Inc. | $87933 | 25052 | -25796 | -50.73% |
| 18 | Banco Bilbao Vizcaya Argentaria, S.A. | $69704 | 20000 | — | NEW BUY |
| 19 | Principal Financial Group Inc | $50295 | 14329 | +1081 | +8.16% |
| 20 | Regions Financial Corp | $44437 | 12660 | +660 | +5.50% |
| 21 | Franklin Resources Inc | $39603 | 11283 | — | NEW BUY |
| 22 | Fifth Third Bancorp | $39417 | 11230 | — | NEW BUY |
| 23 | M&T Bank Corp | $31297 | 11464 | — | NEW BUY |
| 24 | Us Bancorp \De\ | $4254 | 1212 | +65 | +5.67% |
| 25 | Amalgamated Financial Corp. | $480 | 28847 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.